✦ LIBER ✦

Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195

✍ Scribed by Feldman, E; Kalaycio, M; Weiner, G; Frankel, S; Schulman, P; Schwartzberg, L; Jurcic, J; Velez-Garcia, E; Seiter, K; Scheinberg, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trial of a Humanized Anti-CD33

✍ Gibson, Angelia D.; Tallman, Martin S.; Jain, Vinay K. 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 87 KB

Murine and humanized constructs of monoc

✍ Philip C. Caron; Michael A. Schwartz; Man Sung Co; Cary Queen; Ronald D. Finn; M 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 799 KB

398 - Treatment of patients with relapse

✍ E.L. Slevers; I.D. Bernstein; R.T. Spielberger; S.J. Forman; K. Shannon-Dorcy; F 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Efficacy and tolerability of gemtuzumab

✍ Benoit Brethon; Anne Auvrignon; Claire Galambrun; Karima Yakouben; Thierry Lebla 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 259 KB

Phase I/II study of humanized anti-CD33

✍ Yukio Kobayashi; Kensei Tobinai; Akihiro Takeshita; Kensuke Naito; Osamu Asai; N 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 231 KB

Phase I studies of AVE9633, an anti-CD33

✍ Simona Lapusan, Maria B. Vidriales, Xavier Thomas, Stephane de Botton, Anne Vekh 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 482 KB